Showing results (51-60 of 3,180) with videos related to
Sort By:
Pageof 318
Molecular Cancer Research : MCR|June 10, 2015
Decreased eIF3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGFβ Signaling PathwayGuillaume Desnoyers, Laura D Frost, Lynn Courteau, et al.Molecular Cancer Research : MCR|June 18, 2015
Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma GenomeRebecca C Poulos, Julie A I Thoms, Anushi Shah, et al.Molecular Cancer Research : MCR|June 18, 2015
Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 PathwayGregory R Kardos, Hannah C Wastyk, Gavin P RobertsonMolecular Cancer Research : MCR|March 17, 2018
TRPM7 Regulates AKT/FOXO1-Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell CarcinomaZhijian Zhao, Mengping Zhang, Xiaolu Duan, et al.Molecular Cancer Research : MCR|March 18, 2018
β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3-N-Glycan ComplexYukiko Kariya, Midori Oyama, Yasuhiro Hashimoto, et al.Molecular Cancer Research : MCR|January 14, 2018
Novel Intergenically Spliced Chimera, NFATC3-PLA2G15, Is Associated with Aggressive T-ALL Biology and OutcomeJonathan Bond, Christine Tran Quang, Guillaume Hypolite, et al.Molecular Cancer Research : MCR|January 14, 2018
Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt InhibitionJeffrey S Damrauer, Stephanie N Phelps, Katie Amuchastegui, et al.Molecular Cancer Research : MCR|January 14, 2018
Keap1 Inhibits Metastatic Properties of NSCLC Cells by Stabilizing Architectures of F-Actin and Focal AdhesionsBo Wu, Shu Yang, Haimei Sun, et al.Molecular Cancer Research : MCR|January 14, 2018
Epigenetic Reprogramming of Pericentromeric Satellite DNA in Premalignant and Malignant LesionsNadine Heidi Brückmann, Christina Bøg Pedersen, Henrik Jørn Ditzel, et al.Molecular Cancer Research : MCR|March 29, 2018
ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate CancerAvital Lev, Amriti R Lulla, Brian C Ross, et al.Pageof 318